2024

Bimodal imaging: Detection rate of clinically significant prostate cancer is higher in MRI lesions visible to transrectal ultrasound
Falkenbach F, Ahmad-Sterkau F, Kachanov M, Beyersdorff D, Koehler D, Ambrosini F, Ortner G, Maurer T, Graefen M, Budäus L
PROSTATE. 2024;84(16):1448-1455.

PSA-density, DRE, and PI-RADS 5: potential surrogates for omitting biopsy?
Falkenbach F, Ambrosini F, Kachanov M, Ortner G, Maurer T, Köhler D, Beyersdorff D, Graefen M, Budäus L
WORLD J UROL. 2024;42(1):182.

Size of lymph-node metastases in prostate cancer patients undergoing radical prostatectomy: implication for imaging and oncologic follow-up of 2705 lymph-node positive patients
Falkenbach F, Kachanov M, Leyh-Bannurah S, Maurer T, Knipper S, Köhler D, Graefen M, Sauter G, Budäus L
WORLD J UROL. 2024;42(1):.

2023

Outcome of patients with epithelialized cavity formation after excessive vesicourethral anastomotic leak post radical prostatectomy
Filipas D, Graefen M, Fisch M, Steuber T, Heinzer H, Schulz R, Kachanov M, Tennstedt P, Hahn L, Ludwig T, Marks P, Hohenhorst L, Pose R
WORLD J UROL. 2023;41(9):2327-2333.

Targeted Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion Biopsy for Quantitative Gleason 4 Grading Prediction in Radical Prostatectomy Specimens: Implications for Active Surveillance Candidate Selection
Kachanov M, Budäus L, Beyersdorff D, Karakiewicz P, Tian Z, Falkenbach F, Tilki D, Maurer T, Sauter G, Graefen M, Leyh-Bannurah S
EUR UROL FOCUS. 2023;9(2):303-308.

Nachweis einer hereditären hämorrhagischen Teleangiektasie (Morbus Osler) bei singulärer pulmonaler arteriovenöser Malformation
Schick-Bengardt X, Kachanov M, Bannas P, Galow S, Klose H, Woitschach R, Schönnagel B, Oqueka T
PNEUMOLOGIE. 2023;77(Suppl 01):S33.

2022

Suitability of conventional systematic vs. MRI-guided targeted biopsy approaches to assess surgical treatment delay for radical prostatectomy
Kachanov M, Budäus L, Witt J, Wagner C, Zinke J, Fangmeyer B, Schütte A, Spieker T, Beyersdorff D, Graefen M, Rachubinski P, Leyh-Bannurah S
WORLD J UROL. 2022;40(12):2955-2961.

Optimizing Combined Magnetic Resonance Imaging (MRI)-Targeted and Systematic Biopsy Strategies
Kachanov M, Leyh-Bannurah S, Roberts M, Sauer M, Beyersdorff D, Boiko S, Maurer T, Steuber T, Graefen M, Budäus L
J UROLOGY. 2022;207(2):333-340.

Oncologic impact of concomitant prostate cancer characteristics at the time of radical cystoprostatectomy for bladder cancer: a population-based analysis
Kachanov M, Vetterlein M, Soave A, Karakiewicz P, Liakos N, Jankowski T, Pose R, Mandrek M, Fisch M, Witt J, Graefen M, Leyh-Bannurah S
AGING MALE. 2022;25(1):54-61.

Two-year quality of life after robot-assisted radical prostatectomy according to pentafecta criteria and cancer of the prostate risk assessment (CAPRA-S)
Karagiotis T, Witt J, Jankowski T, Mendrek M, Wagner C, Schuette A, Liakos N, Rachubinski P, Urbanova K, Oelke M, Kachanov M, Leyh-Bannurah S
SCI REP-UK. 2022;12(1):.

Pan-segmental intraprostatic lesions involving mid-gland and apex of prostate (mid-apical lesions): assessing the true value of extreme apical biopsy cores
Leyh-Bannurah S, Boiko S, Beyersdorff D, Falkenbach F, Ekrutt J, Maurer T, Graefen M, Kachanov M, Budäus L
WORLD J UROL. 2022;40(7):1653-1659.

Precision-Guidance vs. Systematic Sampling: Optimizing Biopsy Assessment of Secondary Prostate Cancer Suspicious mpMRI Lesions
Rachubinski P, Witt J, Budäus L, Zinke J, Fangmeyer B, Spieker T, Vetterlein M, Rahbar K, Kachanov M, Leyh-Bannurah S
J UROLOGY. 2022;208(6):1203-1213.

Reply by Authors
Rachubinski P, Witt J, Budäus L, Zinke J, Fangmeyer B, Spieker T, Vetterlein M, Rahbar K, Kachanov M, Leyh-Bannurah S
J UROLOGY. 2022;208(6):1213.

Impact of obesity on perioperative, functional and oncological outcomes after robotic-assisted radical prostatectomy in a high-volume center
Sarychev S, Witt J, Wagner C, Oelke M, Schuette A, Liakos N, Karagiotis T, Mendrek M, Kachanov M, Graefen M, Vetterlein M, Meyer C, Tian Z, Leyh-Bannurah S
WORLD J UROL. 2022;40(6):1419-1425.

2021

Combined systematic versus stand-alone multiparametric MRI-guided targeted fusion biopsy: nomogram prediction of non-organ-confined prostate cancer
Leyh-Bannurah S, Kachanov M, Karakiewicz P, Beyersdorff D, Pompe R, Oh-Hohenhorst S, Fisch M, Maurer T, Graefen M, Budäus L
WORLD J UROL. 2021;39(1):81-88.

Chitotriosidase as biomarker for early stage amyotrophic lateral sclerosis: a multicenter study
Steinacker P, Feneberg E, Halbgebauer S, Witzel S, Verde F, Oeckl P, Van Damme P, Gaur N, Gray E, Grosskreutz J, Jardel C, Kachanov M, Kuhle J, Lamari F, Maceski A, Del Mar Amador M, Mayer B, Morelli C, Petri S, Poesen K, Raaphorst J, Salachas F, Silani V, Turner M, Verbeek M, Volk A, Weishaupt J, Weydt P, Ludolph A, Otto M
AMYOTROPH LAT SCL FR. 2021;22(3-4):276-286.

Twenty-year trends in prostate cancer stage and grade migration in a large contemporary german radical prostatectomy cohort
Würnschimmel C, Kachanov M, Wenzel M, Mandel P, Karakiewicz P, Maurer T, Steuber T, Tilki D, Graefen M, Budäus L
PROSTATE. 2021;81(12):849-856.

2020

Minimum Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy Cores Needed for Prostate Cancer Detection: Multivariable Retrospective, Lesion Based Analyses of Patients Treated with Radical Prostatectomy
Leyh-Bannurah S, Kachanov M, Beyersdorff D, Tian Z, Karakiewicz P, Tilki D, Fisch M, Maurer T, Graefen M, Budäus L
J UROLOGY. 2020;203(2):299-303.

Rectal Swabs for Detecting Multidrug Resistant Bacteria Prior to Transrectal Prostate Fusion Biopsy: A Prospective Evaluation of Risk Factor Screening and Microbiologic Findings
Würnschimmel C, Busto Martin L, Leyh-Bannurah S, Oh-Hohenhorst S, Kachanov M, Maurer T, Knipper S, Graefen M, Budäus L
UROLOGY. 2020;136:127-132.

2019

Prediction of Complications in Radical Prostatectomy Prostate Cancer Patients: Simulated Annealing versus Co-Morbidity Indexes
Leyh-Bannurah S, Zaffuto E, Dell'Oglio P, Tian Z, Moschini M, Capitanio U, Briganti A, Montorsi F, Fisch M, Chun F, Kachanov M, Budäus L, Graefen M, Huland H, Karakiewicz P
UROL INT. 2019;102(1):51-59.

2018

Anterior Localization of Prostate Cancer Suspicious Lesions in 1,161 Patients Undergoing Magnetic Resonance Imaging/Ultrasound Fusion Guided Targeted Biopsies
Leyh-Bannurah S, Kachanov M, Beyersdorff D, Preisser F, Tilki D, Fisch M, Graefen M, Budäus L
J UROLOGY. 2018;200(5):1035-1040.

Letzte Aktualisierung aus dem FIS: 23.12.2024 - 23:33 Uhr